Synthesis, in vitro, and in silico study of novel pyridine based 1,3-diphenylurea derivatives as tyrosinase inhibitors
Bioorganic Chemistry · 2024
DOI: 10.1016/j.bioorg.2024.107724 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2024. Verfasst von Anam Rubbab Pasha und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemical Sciences, Bahauddin Zakariya University, Multan 60800, Pakistan; Natural and Medical Sciences Research Centre, University of Ni…. Hauptthemen laut MEDLINE: Monophenol Monooxygenase, Enzyme Inhibitors, Pyridines, Molecular Docking Simulation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Taif University.
Abstract (Originalsprache)
Tyrosinase inhibitors are studied in the cosmetics and pharmaceutical sectors as tyrosinase enzyme is involved in the biosynthesis and regulation of melanin, hence these inhibitors are beneficial for the management of melanogenesis and hyperpigmentation-related disorders. In the current work, a novel series of diphenyl urea derivatives containing a halo-pyridine moiety (5a-t) was synthesized via a multi-step synthesis. In vitro, tyrosinase inhibitory assay results showed that, except for two compounds, the derivatives were excellent inhibitors of human tyrosinase. The average IC50 value of the inhibitors (15.78 μM) is lower than that of kojic acid (17.3 μM) used as the reference compound, indicating that, on average, these molecules are more potent than the reference. Derivative 5a was identified as the most potent human tyrosinase inhibitor of the series, with an IC50 value of 3.5 ± 1.2 μM, approximately 5 times more potent than kojic acid. To get further insights into the nature of binding site interactions, molecular docking and molecular dynamics simulation studies were carried out. Moreover, the evaluation of in silico ADME properties showed a highly favorable profile for the synthesized compounds. These findings suggested that the further development of this class of compounds could be useful to get potent drug-like compounds that can target hyperpigmentation-related disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Chemical Sciences, Bahauddin Zakariya University, Multan 60800, Pakistan; Natural and Medical Sciences Research Centre, University of Nizwa, P.O. Box 33, PC 616, Birkat Al Mauz, Nizwa, Oman.
- Natural and Medical Sciences Research Centre, University of Nizwa, P.O. Box 33, PC 616, Birkat Al Mauz, Nizwa, Oman; Department of Biochemistry, Hazara University, Mansehra, Pakistan.
- Natural and Medical Sciences Research Centre, University of Nizwa, P.O. Box 33, PC 616, Birkat Al Mauz, Nizwa, Oman.
- Department of Biological Sciences and Chemistry, University of Nizwa, Oman.
- Department of Chemistry, Forman Christian College (A Chartered University), Lahore, Pakistan.
- Institute of Chemical Sciences, Bahauddin Zakariya University, Multan 60800, Pakistan.
Förderung
- Taif University
Zitieren
APA
Rubbab Pasha, A., Khan, M., Khan, A., Hussain, J., Al-Rashida, M., Islam, T., Batool, Z., Kashtoh, H., Abdellattif, M. H., Al-Harrasi, A., Shafiq, Z., & Schenone, S. (2024). Synthesis, in vitro, and in silico study of novel pyridine based 1,3-diphenylurea derivatives as tyrosinase inhibitors. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2024.107724
Vancouver
Rubbab Pasha A, Khan M, Khan A, Hussain J, Al-Rashida M, Islam T, et al. Synthesis, in vitro, and in silico study of novel pyridine based 1,3-diphenylurea derivatives as tyrosinase inhibitors. Bioorganic Chemistry. 2024. doi:10.1016/j.bioorg.2024.107724
BibTeX
@article{RubbabPasha2024,
author = {Rubbab Pasha, Anam and Khan, Majid and Khan, Ajmal and Hussain, Javid and Al-Rashida, Mariya and Islam, Talha and Batool, Zahra and Kashtoh, Hamdy and Abdellattif, Magda H and Al-Harrasi, Ahmed and Shafiq, Zahid and Schenone, Silvia},
title = {Synthesis, in vitro, and in silico study of novel pyridine based 1,3-diphenylurea derivatives as tyrosinase inhibitors},
journal = {Bioorganic Chemistry},
year = {2024},
doi = {10.1016/j.bioorg.2024.107724}
}
EUVIMED